Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Presentation TCT 2024

My Personal Algorithm for Primary PCI Post Cardiac Arrest

Presenter: NULL

October 30, 2024

Presentation TCT 2024

Case-Based Presentation: Making the Diagnosis

Presenter: NULL

October 29, 2024

Presentation TCT 2024

How Do I Decide on Choice of Mechanical Circulatory Support in MI: A Personal Perspective

Presenter: NULL

October 29, 2024

Presentation TCT 2024

TCT 748: Early Economic Analysis of Integrated Robotic Assisted Augmented Reality (AR) Visualization for Transcatheter Tricuspid Valve Repair (TTVR) or Percutaneous Tricuspid Trans-Catheter 'Edge-to-Edge' Repair (T-TEER)

Presenter: NULL

October 28, 2024

Presentation TCT 2024

TCT 568: Drug-Coated Balloon Versus Non-Compliant Balloon Angioplasties for Side Branch After Main Vessel Stenting for True Coronary Bifurcation Lesions: The Prospective, Multicenter, Randomized, Blinded DCB-BIF Trial

Presenter: NULL

October 28, 2024

Presentation TCT 2024

TCT 492: One-Year Clinical Outcomes After PCI With AGENT Paclitaxel-Coated Balloon Among Underrepresented Racial and Ethnic Subgroups With In-Stent Restenosis: Analysis of the AGENT IDE Trial

Presenter: NULL

October 28, 2024

Presentation TCT 2023

TopShock Voting (Audience) & Winner Acknowledgement

Presenter: NULL

October 25, 2023

Presentation TCT 2023

Case Resolution: Long-term Therapy

Presenter: NULL

October 25, 2023

News Conference News TCT 2022

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Yael L. Maxwell

September 19, 2022

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

News Conference News TCT 2015

RIVER-PCI: No Advantage to Ranolazine in Patients With Incomplete Revascularization

Yael L. Maxwell

October 13, 2015

Advertisement

My Personal Algorithm for Primary PCI Post Cardiac Arrest

Case-Based Presentation: Making the Diagnosis

How Do I Decide on Choice of Mechanical Circulatory Support in MI: A Personal Perspective

TCT 748: Early Economic Analysis of Integrated Robotic Assisted Augmented Reality (AR) Visualization for Transcatheter Tricuspid Valve Repair (TTVR) or Percutaneous Tricuspid Trans-Catheter 'Edge-to-Edge' Repair (T-TEER)

TCT 568: Drug-Coated Balloon Versus Non-Compliant Balloon Angioplasties for Side Branch After Main Vessel Stenting for True Coronary Bifurcation Lesions: The Prospective, Multicenter, Randomized, Blinded DCB-BIF Trial

TCT 492: One-Year Clinical Outcomes After PCI With AGENT Paclitaxel-Coated Balloon Among Underrepresented Racial and Ethnic Subgroups With In-Stent Restenosis: Analysis of the AGENT IDE Trial

TopShock Voting (Audience) & Winner Acknowledgement

Case Resolution: Long-term Therapy

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

More DAPT Duration Data, More Calls to Tailor to Individual Patients

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

RIVER-PCI: No Advantage to Ranolazine in Patients With Incomplete Revascularization

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content